{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T10:55:09Z","timestamp":1789815309522,"version":"4.0.1"},"reference-count":29,"publisher":"BMJ","issue":"6643","license":[{"start":{"date-parts":[[1988,7,23]],"date-time":"1988-07-23T00:00:00Z","timestamp":585619200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bmj.com\/company\/legal-information\/terms-conditions\/legal-information\/tdm-licencepolicy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ"],"published-print":{"date-parts":[[1988,7,23]]},"abstract":"<jats:p>The relation of the use of antithyroid drugs to the risk of developing agranulocytosis and aplastic anaemia was evaluated in a population based case-control study with patients from Israel and seven regions in Europe. Data were obtained from cases and hospital controls by interview. Use of antithyroid drugs in the week before the onset of illness was compared in 262 patients with agranulocytosis and 1771 controls. Forty five patients (17%) and five controls (0.3%) had used antithyroid drugs. The relative risk was estimated to be 102 (95% confidence interval 38 to 275) taking into account confounding by other factors, including the use of other drugs. The excess risk for use of antithyroid drugs in any one week was estimated to be 6.3 cases of agranulocytosis per million users. Use of antithyroid drugs in a five month period ending one month before admission to hospital was compared in 135 patients with aplastic anaemia and 2145 controls. Four patients (3%) and five controls (0.2%) had taken drugs; the estimate of relative risk was 9.2 (95% confidence interval 1.8 to 47) after control for confounding. The estimate of excess risk of agranulocytosis with the use of antithyroid drugs was lower than found previously. Although the excess risk for aplastic anaemia was not calculated, these data suggest that it is very low.<\/jats:p>","DOI":"10.1136\/bmj.297.6643.262","type":"journal-article","created":{"date-parts":[[2009,4,2]],"date-time":"2009-04-02T15:19:55Z","timestamp":1238685595000},"page":"262-265","source":"Crossref","is-referenced-by-count":63,"title":["Risk of agranulocytosis and aplastic anaemia in relation to use of antithyroid drugs. International Agranulocytosis and Aplastic Anaemia Study."],"prefix":"10.1136","volume":"297","member":"239","published-online":{"date-parts":[[1988,7,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1210\/endo-32-2-185","article-title":"Effect of sulfonamides and thioureas on the thyroid gland and basal metabolism","volume":"32","author":"MacKenzie, C.G.; MacKenzie, J.B.","year":"1943","unstructured":"MacKenzie CG, MacKenzie JB. Effect of sulfonamides and thioureas on the thyroid gland and basal metabolism. Endocrinology 1943;32:185-209.","journal-title":"Endocrinology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1210\/endo-32-2-210","article-title":"Action of certain sulfonamides and of thiourea upon the function of the thyroid gland of the rat","volume":"32","author":"Astwood, E.B.; Sullivan, J.; Bissell, A.","year":"1943","unstructured":"Astwood EB, Sullivan J, Bissell A, et al. Action of certain sulfonamides and of thiourea upon the function of the thyroid gland of the rat. Endocrinology 1943;32:210-25.","journal-title":"Endocrinology"},{"issue":"2","key":"ref_3","first-page":"333","article-title":"The relative toxicity of antithyroid drugs","volume":"1962","author":"Trotter, W.R.","unstructured":"Trotter WR. The relative toxicity of antithyroid drugs. Journal of New Drugs 1962;2:333-43.","journal-title":"Journal of New Drugs"},{"key":"ref_4","first-page":"249","article-title":"Antithyroid therapy and leukocytes","volume-title":"hematologic reactions","author":"Ahn, Y.S.; Yunis, A.A.","year":"1974","unstructured":"Ahn YS, Yunis AA. Antithyroid therapy and leukocytes. In: Dimitrol NV, Nodine JH, eds. Drugs and hematologic reactions. New York: Grune and Stratton, 1974:249-59."},{"key":"ref_5","first-page":"339","article-title":"Agranulocytosis and antithyroid drugs. West3'","volume":"126","author":"Rosove, M.H.","year":"1977","unstructured":"Rosove MH. Agranulocytosis and antithyroid drugs. West3' Med 1977;126: 339-43.","journal-title":"Med"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/BF00607096","article-title":"International Agranulocytosis and Aplastic Anemia Study. The design of a study of the drug etiology of agranulocytosis and aplastic anemia","volume":"24","year":"1983","unstructured":"International Agranulocytosis and Aplastic Anemia Study. The design of a study of the drug etiology of agranulocytosis and aplastic anemia. EurJ Clin Pharmacol 1983;24:833-6.","journal-title":"EurJ Clin Pharmacol"},{"key":"ref_7","first-page":"1749","article-title":"International Agranulocytosis and Aplastic Anemia Study. Risks of agranulocytosis and aplastic anemia: a first report of their relation to drug use with special reference to analgesics","volume":"256","year":"1986","unstructured":"International Agranulocytosis and Aplastic Anemia Study. Risks of agranulocytosis and aplastic anemia: a first report of their relation to drug use with special reference to analgesics. 7AMA 1986;256:1749-57."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1001\/archinte.144.8.1687","article-title":"Granulocytotoxic antibodies in a patient with propylthiouracil-induced agranulocytosis","volume":"144","author":"Guffy, M.M.; Gocken, N.E.; Burns, C.P.","year":"1984","unstructured":"Guffy MM, Gocken NE, Burns CP. Granulocytotoxic antibodies in a patient with propylthiouracil-induced agranulocytosis. Arch Intern Med 1984;144: 1687-8.","journal-title":"Arch Intern Med"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2141.1986.tb04130.x","article-title":"Agranulocytosis induced by propylthiouracil: evidence of a drug dependent antibody reacting with granulocytes, monocytes and haematopoietic progenitor cells","volume":"64","author":"Fibbe, W.E.; Claas, F.H.; Van der Star-Dijkstra, W.; Schaafsma, M.R.; Meyboom, R.H.; Falkenburg, J.H.","year":"1986","unstructured":"Fibbe WE, Claas FH, Van der Star-Dijkstra W, Schaafsma MR, Meyboom RH, Falkenburg JH. Agranulocytosis induced by propylthiouracil: evidence of a drug dependent antibody reacting with granulocytes, monocytes and haematopoietic progenitor cells. BrJ Haematol 1986;64:363-73.","journal-title":"BrJ Haematol"},{"key":"ref_10","first-page":"124","article-title":"Immunological reactions involving leukocytes. III. Agranulocytosis induced by antithyroid drugs","volume":"138","author":"Bilezikian, S.B.; Laleli, Y.; Tsan, M.F.","year":"1976","unstructured":"Bilezikian SB, Laleli Y, Tsan MF, et al. Immunological reactions involving leukocytes. III. Agranulocytosis induced by antithyroid drugs. J7ohns HopkinsMedJ 1976;138:124-9."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0140-6736(78)90915-7","article-title":"Drug-induced immunological neutropenia","volume":"i:","author":"Weitzman, S.A.; Stossel, T.P.","year":"1978","unstructured":"Weitzman SA, Stossel TP. Drug-induced immunological neutropenia. Lancet 1978;i: 1068-72.","journal-title":"Lancet"},{"key":"ref_12","first-page":"380","article-title":"Statistical methods in medical research","author":"Armitage, P.","year":"1971","unstructured":"Armitage P. Statistical methods in medical research. New York: Wiley, 1971:380-4."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/oxfordjournals.aje.a121617","article-title":"Proportion of disease caused or prevented by a given exposure, trait or intervention","volume":"99","author":"Miettinen, O.S.","year":"1974","unstructured":"Miettinen OS. Proportion of disease caused or prevented by a given exposure, trait or intervention. AmJ Epidemiol 1974;99: 325-32.","journal-title":"AmJ Epidemiol"},{"key":"ref_14","first-page":"38","article-title":"Modern epidemiology","author":"Rothman, K.J.","year":"1986","unstructured":"Rothman KJ. Modern epidemiology. Boston: Little Brown, 1986:38-9."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/oxfordjournals.aje.a112220","article-title":"Estimability and estimation in case referent studies","volume":"103","author":"Miettinen, O.S.","year":"1976","unstructured":"Miettinen OS. Estimability and estimation in case referent studies. Am J Epidemiol 1976;103:226-35.","journal-title":"Am J Epidemiol"},{"key":"ref_16","article-title":"Case-control studies: design, conduct, analysis","author":"Schlesselman, J.J.","year":"1982","unstructured":"Schlesselman JJ. Case-control studies: design, conduct, analysis. New York: Oxford University Press, 1982."},{"key":"ref_17","first-page":"1680","article-title":"Metamizol: een honderdjarige treurnis","volume":"131","author":"Shapiro, S.; Levy, M.","year":"1987","unstructured":"Shapiro S, Levy M. Metamizol: een honderdjarige treurnis. Ned Tijdschr Geneeskd 1987;131:1680-1.","journal-title":"Ned Tijdschr Geneeskd"},{"key":"ref_18","first-page":"216","article-title":"Peripheral blood leucocytes in thyrotoxicosis (Graves' disease) as studied by conventional light microscopy. Clin Exp Immunol","volume":"27","author":"Irvine, W.J.; Wu, F.C.W.; Urbaniak, S.J.","year":"1977","unstructured":"Irvine WJ, Wu FCW, Urbaniak SJ, et al. Peripheral blood leucocytes in thyrotoxicosis (Graves' disease) as studied by conventional light microscopy. Clin Exp Immunol 1977;27:216-2 1."},{"key":"ref_19","first-page":"1353","article-title":"Antithyroid drugs. NEnglJ7Med","volume":"311","author":"Cooper, D.S.","year":"1984","unstructured":"Cooper DS. Antithyroid drugs. NEnglJ7Med 1984;311:1353-62."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1365-2265.1986.tb01712.x","article-title":"Evidence that antithyroid drugs induce remissions in Graves' disease by modulating thyroid cellular activity","volume":"25","author":"Volpe, R.; Karlsson, F.A.; Jansson, R.","year":"1986","unstructured":"Volpe R, Karlsson FA, Jansson R, et al. Evidence that antithyroid drugs induce remissions in Graves' disease by modulating thyroid cellular activity. Clin Endocrinol (Oxf) 1986;25:453-62.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJM198701013160104","article-title":"Induction of circulating activated suppressor-like T cells by methimazole therapy for Graves'","volume":"316","author":"Totterman, T.H.; Karlsson, F.A.; Bengtsson, M.; Mendel-Hartvig, I.","year":"1987","unstructured":"Totterman TH, Karlsson FA, Bengtsson M, Mendel-Hartvig I. Induction of circulating activated suppressor-like T cells by methimazole therapy for Graves' disease. N EnglJ Med 1987;316: 15-22.","journal-title":"disease. N EnglJ Med"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1210\/jcem-58-5-868","article-title":"Invitroimmunoactivitytopropylthiouracil, methimazole, and carbimazole in patients with Graves' disease: a possible cause of antithyroid drug-induced agranulocytosis","volume":"58","author":"Wall, JR, Fang; SL, KurokiT; etal","year":"1984","unstructured":"Wall JR, Fang SL, KurokiT, etal. Invitroimmunoactivitytopropylthiouracil, methimazole, and carbimazole in patients with Graves' disease: a possible cause of antithyroid drug-induced agranulocytosis. J Clin Endocrinol Metab 1984;58:868-72.","journal-title":"J Clin Endocrinol Metab"},{"key":"ref_23","first-page":"414","article-title":"Methimazole toxicity from high doses","volume":"77","author":"Wiberg, J.J.; Nuttall, F.Q.","year":"1972","unstructured":"Wiberg JJ, Nuttall FQ. Methimazole toxicity from high doses. AnnInternMed 1972;77:414-6.","journal-title":"AnnInternMed"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.0954-6820.1982.tb03216.x","article-title":"Drug-induced neutropenia: a survey for Stockholm 1973-1978","volume":"212","author":"Arneborn, P.; Palmblad, J.","year":"1982","unstructured":"Arneborn P, Palmblad J. Drug-induced neutropenia: a survey for Stockholm 1973-1978. Acta Med Scand 1982;212:289-92.","journal-title":"Acta Med Scand"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"26","DOI":"10.7326\/0003-4819-98-1-26","article-title":"Agranulocytosis associated with antithyroid drugs. Effects of patient age and drug dose","volume":"98","author":"Cooper, D.S.; Goldminz, D.; Levin, A.A.","year":"1983","unstructured":"Cooper DS, Goldminz D, Levin AA, et al. Agranulocytosis associated with antithyroid drugs. Effects of patient age and drug dose. Ann Intern Med 1983;98:26-9.","journal-title":"Ann Intern Med"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0308-2261(21)00200-9","article-title":"Drug-induced aplastic anemia: clinical aspects","volume":"9","author":"Heimpel, H.; Heit, W.","year":"1980","unstructured":"Heimpel H, Heit W. Drug-induced aplastic anemia: clinical aspects. Clin Hematol 1980;9:641-62.","journal-title":"Clin Hematol"},{"key":"ref_27","first-page":"412","article-title":"Aplastic anemia secondary to methimazole: case report and review of hematologic side effects","volume":"30","author":"Edell, S.L.; Bartuska, D.G.","year":"1975","unstructured":"Edell SL, Bartuska DG. Aplastic anemia secondary to methimazole: case report and review of hematologic side effects. J Am Med Wom Assoc 1975;30:412-3.","journal-title":"J Am Med Wom Assoc"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0140-6736(68)92089-8","article-title":"Aplastic anaemia after propylthiouracil","volume":"i:","author":"Aksoy, M.; Erdem, S.","year":"1968","unstructured":"Aksoy M, Erdem S. Aplastic anaemia after propylthiouracil. Lancet 1968;i: 1379.","journal-title":"Lancet"},{"key":"ref_29","first-page":"634","article-title":"Drugs, chemicals and blood dyscrasias","author":"Swanson, M.; Cook, R.","year":"1977","unstructured":"Swanson M, Cook R. Drugs, chemicals and blood dyscrasias. Hamilton, Illinois: Drug Intelligence Publications, 1977:634."}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj.297.6643.262","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.297.6643.262","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T17:34:14Z","timestamp":1765474454000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.297.6643.262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988,7,23]]},"references-count":29,"journal-issue":{"issue":"6643","published-online":{"date-parts":[[1988,7,23]]},"published-print":{"date-parts":[[1988,7,23]]}},"alternative-id":["10.1136\/bmj.297.6643.262"],"URL":"https:\/\/doi.org\/10.1136\/bmj.297.6643.262","relation":{},"ISSN":["0959-8138","1468-5833"],"issn-type":[{"value":"0959-8138","type":"print"},{"value":"1468-5833","type":"electronic"}],"subject":[],"published":{"date-parts":[[1988,7,23]]}}}